TheraMe!

TheraMe uses microfluidic technology to test over 100 therapy options from tiny cancer biopsies, enabling comprehensive drug screening. Proprietary computational programs and machine learning analyze the data to recommend the most effective personalized treatment within 8‑10 business days. The platform also supports repeat screenings to monitor resistance and identify second‑line options.

Traction 4/10

HQ unknown

Founded 20237300+ followers

Data & Analytics
Biotechnology
Healthcare Technology

Updated 6 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Ngoc-Hien Du

Chief Innovation Officer

Product

Features

TheraMe uses microfluidic technology to test over 100 therapy options from tiny cancer biopsies, enabling comprehensive drug screening. Proprietary computational programs and machine learning analyze the data to recommend the most effective personalized treatment within 8‑10 business days. The platform also supports repeat screenings to monitor resistance and identify second‑line options.